The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
860k
https://www.lse.co.uk/ShareTrades.asp?shareprice=PXS.GB.PL&share=Provexis-Plc
Hi mate ihow many shares were sold ,i have been trying to find it can not get the chunky sell trade,could you help ,thank you
Hi mate ihow many shares were sold ,i have been trying to find it can not get the chunky sell trade,could you help ,thank you
Not saying it's not alfista, I just don't think dsmv would be messing about with such small trades.
That was a big sell
So .78 is the Buy price, another chunky Sell on Aquis.
Still suspicious gix.
Well done on buying shares before the company existed Jimmy, that's quite a feat !
Lots of lth's here Cagney.
Recently went through my purchase history for PXS to work out my average, and first bought these on 9th Sept 2009, current average is 0.54p
If this were the only share I'd bought would have lost my mind by now, but happy to hold and see where we get to over next 2 to 3 years..
It must be 20 years ago that I held PXS,I had around 200k which cost 1 3/4p per share at the time.After about 2 years I got rid,is there anyone here who's held them since those far off day's?All the main tipsters say you have to have patients to be a profitable investor,but of course it's not always true.
Because he is retired English teacher and got nothing to do other the do the spell check.
Must be a blue moon today lol.
Cor, with humour like that, you could be the new "Barry" Oh dear, oh dear oh dear etc. Good to see you haven't lost your sense of humour despite being emotionally tied to PSX since Adam was a lad!!
Enjoy the weekend.
Why, is he leaving SAR?
alfista, IMO there is no evidence that would suggest DSMV is selling atm.
There has been 2 or 3 larger 1+ million trades since the new agreements with dsm were announced so if it is them selling then it could take them a long long time.
Alf,
They do use the 'substantial multiples' when referring to the DSM contract. I think that is separate from the BH, as it is in a different section of the RNS'. However, there is no real way of knowing. I am choosing to read it as two separate things.
Off topic but I see it's all gone tits-up at SIS this morning. CFO left recently now growth lower than expected and costs rising. No doubt our former CEO will be able to explain why...
Perhaps you're calculating the BH order potential twice, since I think that's what was referred to in the update. But, if there are other non China brands ready to launch, that alone could be multiples as you describe.
As for the By Health orders, with a target market of 4-500 million consumers, I think volumes could be much higher that your estimate, but that may be countered by lower margins.
Only musing, it's for each to make their own decisions, as ever.
BTW, does anyone suspect that we are seeing DSMV slowly exiting?
Dr. H,
Probably you are not too far from your figure. So probably a offer of ~6p/7p should be reasonable.
Trying to untangle to smoke and mirrors.
So in the year 20/21 the company took in £505k revenue, £358k of which was from DSM. Then lets use the £358 figure and assume that PXS only receive half of the total income. That gives us £358 * 2 = £716k in total FF sales.
DSM’ prospective sales pipeline value stands at ‘substantial multiples’ of existing annual sales. So if we assume that ‘substantial multiples’ means above 5-fold. Then let’s assume 5.
That gives us £716k * 5 = £3.58m
Then we have BH that will be ordering ‘multiple’ of current FF volumes/sales. Lets assume ‘multiple’ means 3-fold. £716k * 3 = £2.15m
So the total forecast, being conservative, is £3.58m + £2.15m = £5.73m.
Then that is BH initial orders. On top of that, BH have more product launches and the distribution side and we are informally informed that “many multinational food and beverage companies have expressed their intention to cooperate, which may provide new choices for the general public.”.
So looking at it like this, we can see that the company should now move from loss-making to making over £5m income and beyond in the next few years.
They will be paying DSM a fee for several years. So will lose a chunk of that.
I think that will give us a market cap of circa £100m, 5 times what it is now.
I know nobody knows, but how far out does everyone think I am?
What good is all these reports ,when the sp is so low
You forgot Life-Space for probiotic / gut health. That may become a key area going forwards.
Pretty clear BH are in the business developing products for each of the specific categories
http://www.sfdachina.com/info/86-1.htm
Keylid” for bone and joint health #6
“Jian An Shi” for liver health #7
“EASEYE” for eye health #8
“Shu Bai Ning” for cerebro-cardiovascular health #19
The recently uncovered patents cover #13 & #16.
Looking at the list FF naturally is the blood pressure #19
FF could also address fatigue #3, anoxia endurance #4, antioxidative #15 as well as a few more
W-bingo-anyone-$
I am sure their intention is to use the results in a claim but that doesn't mean they "have applied for Blue Cap".
One thing is for sure, There is a lot going on at By-health wrt Fruitflow that we don't know about.
With this statement “By-Health has recently updated its website (see www.by-health.com/en/aboutus) stating that it has completed: 'Research comprehensively in the cardiovascular health area. We have developed a new product made with Fruitflow®, popularly known as 'natural Aspirin'. It helps to maintain normal platelet aggregation.'”. It’s clear that the last 3 studies are for a different claim imo
gix
what would be the point of the very focused studies if they had no intention to use the results in a claim ? BH have had soooo much time, I expect they have done more studies, beyond what is included in the patents, that support their application.
W-debate-not-dead-then-$